New Market Report Now Available: Semprus BioSciences - Product Pipeline Analysis, 2013 Update

Semprus BioSciences (Semprus) is a biomedical company. The company develops functional surfaces to prevent medical device complications. It concentrates on developing innovative and multi-faceted approaches that can solve complications associated with medical devices. Semprus pipeline Semprus Sustain Technology is a permanent non-leaching biomaterial modification to the device surface, and expected to improve patient outcomes by preventing serious medical complications, such as infection, blood clots, improper healing, and cell overgrowth. The company's other products are polyurethane, silicon and titanium. It was acquired by Teleflex, Inc. in May 2012. Semprus is headquartered in Massachusetts, the US.

Full Report Details at
- http://www.fastmr.com/prod/643634_semprus_biosciences_product_pipeline_analysis.aspx?afid=303

This report is a source for data, analysis and actionable intelligence on the Semprus BioSciences portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

* Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
* Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
* Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
* Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
* Data on relevant clinical trials and product patent details, wherever applicable.
* Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Get this Report

* Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
* Design and develop your product development, marketing and sales strategies.

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

You may also be interested in these related reports:

- Predictive Biosciences, Inc. - Product Pipeline Analysis, 2013 Update
- Nuvera Biosciences, Inc. - Product Pipeline Analysis, 2013 Update
- Nanospectra Biosciences, Inc. - Product Pipeline Analysis, 2013 Update
- TEI Biosciences, Inc. - Product Pipeline Analysis, 2013 Update
- MediPoint: Peripheral Vascular Stents for the Lower Extremity - APAC Analysis and Market Forecasts